A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Phase 2 Terminated
4 enrolled 9 charts
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Phase 2 Withdrawn
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Terminated
35 enrolled
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Phase 2 Terminated
2 enrolled 4 charts
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Phase 2 Withdrawn
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
Phase 2 Unknown
160 enrolled
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Phase 2 Terminated
41 enrolled 12 charts
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202)
Phase 2 Completed
21 enrolled 6 charts
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
Randomized Amifostine For SCCHN
Phase 2 Completed
58 enrolled
Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
Phase 2 Completed
10 enrolled
Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
Phase 2 Unknown
20 enrolled
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
Phase 2 Unknown
25 enrolled
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Phase 2 Completed
37 enrolled
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
Phase 2 Unknown
40 enrolled
Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
Phase 2 Completed
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
34 enrolled
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Phase 2 Terminated
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Phase 2 Completed
130 enrolled
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Phase 2 Completed
94 enrolled
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Phase 2 Completed
24 enrolled
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
Phase 2 Completed
20 enrolled
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
Phase 2 Terminated
5 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
Phase 2 Completed
80 enrolled
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
Phase 2 Terminated
3 enrolled 2 charts
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
Phase 2 Completed
57 enrolled
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer
Phase 2 Completed
30 enrolled 13 charts
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
Phase 2 Completed
25 enrolled
Amifostine for Head and Neck Irradiation in Lymphoma
Phase 2 Completed
75 enrolled
Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
Phase 2 Completed
27 enrolled
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
Phase 2 Completed
130 enrolled